Selenium supplements (sodium–selenite) used alone at 1-2 mg per day repeatedly have been shown to   reduce hemorrhagic fever mortality rates by an average of approximately 60%. In a trial of 1.2 mg of sodium-selenite a day at an Ebola treatment unit (ETU) in Liberia, selenium increases survival rates from 44% to 68% - a 54.4% improvement. If the correct dose of 2.0 mg had been used survival should have increased to 75%. In a small test in Sierra Leone 1.6 mg of selenium a day helped patients feel better after one day and stronger after two days. It saved the first two patients treated including a 60-year-old man who should have died.        In a controlled clinical trial of selenium supplements treating epidemic hemorrhagic fever [EHF], Chinese         doctors used 2mg selenium per day to treat EHF. In fulminate cases the mortality rate fell from 100% to              37.6%. In all...